ArticleCancer immunology, immunotherapy : CII2021

Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).

Yeseul Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.